Aptus Capital Advisors, LLC Abb Vie Inc. Transaction History

Aptus Capital Advisors, LLC

$4.95 Billion
Q1 2024

A detailed history of Aptus Capital Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 54,999 shares of ABBV stock, worth $9.2 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

54,999

Previous 50,326 9.29%

Holding current value

$9.2 Million

Previous $7.8 Million 28.41%

% of portfolio

0.2%

Previous 0.22%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $746,838 - $850,953	4,673 Added 9.29%	54,999 $10 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $666,534 - $750,674	-4,844 Reduced 8.78%	50,326 $7.8 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $116,757 - $135,164	874 Added 1.61%	55,170 $8.22 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $1.71 Million - $2.12 Million	-12,873 Reduced 19.17%	54,296 $7.32 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $535,780 - $617,030	3,705 Added 5.84%	67,169 $10.7 Million

Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $1.09 Million - $1.31 Million	7,903 Added 14.22%	63,464 $10.3 Million
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $2.34 Million - $2.69 Million	-17,458 Reduced 23.91%	55,561 $7.46 Million
Q2 2022 Jul 29, 2022	BUY	$137.62 - $174.96 $3.7 Million - $4.71 Million	26,921 Added 58.4%	73,019 $11.2 Million
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $698,834 - $867,056	-5,295 Reduced 10.3%	46,098 $7.47 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $764,149 - $966,870	7,113 Added 16.06%	51,393 $6.96 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $933,447 - $1.06 Million	8,773 Added 24.71%	44,280 $4.78 Million
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $472,813 - $526,741	4,494 Added 14.49%	35,507 $4 Million
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $83,272 - $91,672	814 Added 2.7%	31,013 $3.36 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $21,168 - $28,580	-263 Reduced 0.86%	30,199 $3.24 Million
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $100,085 - $117,466	1,165 Added 3.98%	30,462 $2.67 Million
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $117,978 - $157,873	1,608 Added 5.81%	29,297 $2.88 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $1.84 Million - $2.8 Million	-28,602 Reduced 50.81%	27,689 $2.11 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $578,626 - $723,985	8,022 Added 16.62%	56,291 $4.98 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $1.79 Million - $2.16 Million	28,501 Added 144.18%	48,269 $3.66 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $20,104 - $25,697	306 Added 1.57%	19,768 $1.44 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $96,425 - $113,487	1,250 Added 6.86%	19,462 $1.57 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $1.42 Million - $1.75 Million	18,212 New	18,212 $1.68 Million

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Account

Aptus Capital Advisors, LLC Abb Vie Inc. Transaction History